Skip to page content

Toggle Search

Publications from the Drug Policy Research Center

Skip to results

377 Results

number of items to display at a time

Aug 31, 2026

Illegal Markets: An Important Domain for Applied Science

This paper introduces a Special Feature analyzing nine illegal markets through a common lens on their structure and operation, arguing that illegal markets warrant sustained scientific study as a distinct field of applied science.
Aug 14, 2026

Stability and Turbulence in Illegal Drug Markets

This article provides a primer on illegal drug markets, with a focus on the structure and nature of these markets and the enterprises involved.
Aug 10, 2026

Clarifying Debates About Drug Decriminalization

This essay aims to reduce confusion about what decriminalization means and offer insights that will hopefully improve future policy debates.
Aug 4, 2026

Veterans and Psychedelics

RAND researchers and expert panelists discuss new findings on U.S. veterans’ use and views of specific psychedelics, related clinical research, and the future of U.S. psychedelics policies affecting veterans.
Aug 3, 2026

Branded Packaging Raises Likelihood of Cigarette Purchasing in an Experimental Retail Setting by Increasing Craving

This study tested whether cigarette craving and perceived health harms mediate the effect of branded packaging on cigarette purchasing in a simulated retail environment.
Jul 16, 2026

Association of Coverage-Promoting Policies With Initiation and Discontinuation of Buprenorphine Treatment During Medicaid Unwinding

We examined associations between coverage-promoting policies and changes in initiation and discontinuation of buprenorphine treatment during Medicaid unwinding.
Jun 23, 2026

U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences

In this report, the authors present new data on U.S veterans’ use of specific psychedelic substances (such as psilocybin mushrooms, LSD, and ibogaine), their psychedelics policy preferences, and how these compare with nonveterans.
May 22, 2026

Preventing Alcohol and Cannabis-Impaired Driving Among Adolescents: Effects of a Web-Intervention in a Driver Education Program

Evaluates a single-session web intervention added to driver education for adolescents in Colorado. WebCHAT participants showed lower perceived peer alcohol and cannabis use norms at 6 months. Both groups reduced substance use and perceived impaired driving as riskier.
Apr 29, 2026

Indiana's Cannabis Landscape

This report presents educational information and insights for those who are evaluating Indiana's cannabis policies or considering potential alternatives.
Apr 29, 2026

Considering the Consequences of Changing Cannabis Policy in Indiana

This report presents educational information and insights for those who are evaluating Indiana's cannabis policies or considering potential alternatives.
Apr 9, 2026

Poppers, Nitrous, and Beyond: Patterns of Inhalant Use Across Sexual Identity Groups in the U.S., 2021-2023

We analyzed nationally representative 2021-2023 National Survey on Drug Use and Health data, estimating prevalence of lifetime, past-year, and past-month inhalant use by sexual identity, sex, and age.
Feb 24, 2026

Public Opinion on Legalizing Psychedelics

An increasing number of U.S. states are implementing or considering changes to psychedelics policies. Using data from the 2025 RAND Psychedelics Survey, the authors examine public opinion about legalizing psilocybin mushrooms, LSD, and MDMA.

First
Previous
Page 1 of 32
Next
Last

Explore More Drug Policy-Related Research

Please visit our RAND Topics pages for a complete research archive on these and other drug policy-related research topics.

Researcher Spotlight

Rosanna Smart

Codirector, RAND Drug Policy Research Center; Senior Economist; Professor of Policy Analysis, RAND School of Public Policy